Blood-Brain Barrier Protein IgG

Measures IgG, IgA, and IgM antibodies against major proteins in the blood-brain barriers (S100B and Claudin-5) which maintain the integrity of the biological door against neuroautoimmunity and neurodegenerative disorders. Detects breaches of the blood-brain barriers due to various factors, including gut bacterial toxins, gut-originated amyloid beta protein and peptides, and many environmental factors, such as foods, toxic chemicals, and pathogens. This array also helps in investigating traumatic brain injuries, sport-related or otherwise. Developed, published, and patented by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2012, 2013, 2014, 2015, 2017, 2019, 2020, and 2024.

Measures IgG, IgA, and IgM antibodies against major proteins in the blood-brain barriers (S100B and Claudin-5) which maintain the integrity of the biological door against neuroautoimmunity and neurodegenerative disorders. Detects breaches of the blood-brain barriers due to various factors, including gut bacterial toxins, gut-originated amyloid beta protein and peptides, and many environmental factors, such as foods, toxic chemicals, and pathogens. This array also helps in investigating traumatic brain injuries, sport-related or otherwise. Developed, published, and patented by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2012, 2013, 2014, 2015, 2017, 2019, 2020, and 2024.

Measures IgG, IgA, and IgM antibodies against bacterial toxins, tight junction and cytoskeletal proteins (Array 2, 22), and blood-brain barrier proteins (Array 20).Detects disturbance of gut flora in the small and large intestine, and damage done to the gut and blood-brain structures that set the stage not only for leaky gut and leaky brain, but for the development of SIBO/IBS, inflammation, autoimmunity, neuroautoimmunity, and neurodegenerative disorders.